Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.

Biotechnology

Acticor Biotech

Gilles Avenard

Antoine Lebel

Sandra Lourenço-Lopes

Alexandra Brochand

Véronia Safwat

Sophie Binay

Marion Galaup

Eric Cohen

Elie Toledano

Victoria Rutman

Yannick Plétan

Laurie Jullien

The executive team at Acticor Biotech has experience in finance, medicine, and company diagnostics. They have worked as CEOs, CFOs, and Board Members for various companies in different industries. They also have a variety of educational backgrounds, with degrees in medicine and company diagnostic audit. This experience and knowledge gives them the ability to successfully lead Acticor Biotech.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Acticor Biotech

Leadership Team

Board of Directors